Share on Google Plus Share on Twitter 8 Share on Facebook 10 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit 1 Share on StumbleUpon Tell A Friend 16 (35 Shares)  
Printer Friendly Page Save As Favorite View Favorites View Stats   16 comments

General News

Why Were These Drugs Approved?

By       Message Martha Rosenberg     Permalink
      (Page 1 of 1 pages)
Related Topic(s): ; ; ; ; ; ; ; ; ; ; (more...) , Add Tags  (less...) Add to My Group(s)

Must Read 9   Well Said 7   News 5  
View Ratings | Rate It

opednews.com Headlined to H2 5/11/12

Author 1353
Become a Fan
  (79 fans)
- Advertisement -

Like Vioxx, Merck's expensive "super aspirin" that caused thousands of cardiovascular events before being recalled, Merck's Fosamax, the first bisphosphonate bone drug, flew out of the FDA with only a six-month review.

And like Vioxx, the true dangers of the drug class (that includes Fosamax, Boniva and Reclast) only surfaced after being "tested" on the guinea pig know as John Q Public.

Now, people are asking why the bone drugs were ever approved.

Like Vioxx, there were early indications of Fosamax's risks but they did not prevent wide marketing.   Merck received 1,213 adverse-effect reports soon after the drug's approval, which included 32 hospitalized patients with adverse esophageal effects, 17 with "severe" effects, and two who were "temporarily disabled," reported the New England Journal of Medicine. One woman who took Fosamax and only remained upright for 30 minutes not 60 minutes as directions say, had to be admitted to the Mayo Clinic with "severe ulcerative esophagitis affecting the entire length of the esophagus" and had to be fed intravenously.

And there were other safety signals. Bisphosphonate patients were found to be at greater risk for osteonecrosis of the jaw--death of the jawbone--after in-office dental procedures.   They were found to be at greater risk for irregular heart beat, intractable pain and at double the risk of esophageal cancer, according to medical reports.

Then, in 2010, after millions of women were taking the widely advertised bisphosphonates, studies revealed they sometimes caused the very fractures they were supposed to prevent!


Thanks, Big Pharma by Martha Rosenberg
 

"Long-term use of osteoporosis drugs linked to hip breaks," said USA Today . "Increased risk of fracture with bisphosphonates," said the Associated Press. "Drugs to build bones may weaken them," said the New York Times, who reported that the thigh bones of patients on bisphosphonates have "simply snapped while they were walking or standing," after "weeks or months of unexplained aching."

- Advertisement -

Soon after the FDA met in 2011 to determine how long patients could safely remain on the drugs (assuming they were safe at all), an article in New England Journal of Medicine suggested that 90 percent of women who have been getting bone scans, devised by Big Pharma to sell bone drugs say published reports, did not need them. Oops.

In April, a study in the Canadian Medical Association Journal found patients on bisphosphonates were at higher risk of developing the eye disorders scleritis and uveitis.   And this week the FDA announced that the bisphosphonates may stop working after a while. The FDA's analysis "found little if any benefit from the drugs after three to five years of use," reported the New York Times.

 

As many as 60 percent to 70 percent of current users "would be candidates for stopping the drugs after three to five years," reports the Times --a diplomatic way of saying they were taking drugs for naught.

Why did the FDA rush to approve bone drugs which turned out to have links to cancer, jawbone death, heart problems, intractable pain and eye disorders? Drugs which actually cause fractures and apparently cease working while patients take them?   Why did it foster Merck's apparent marketing plan of making quick money before risks surfaced? See: Vioxx? END

- Advertisement -

Martha Rosenberg's first book, Born with a Junk Food Deficiency: How Flaks, Quacks, and Hacks Pimp the Public Health, was published last week.

 

- Advertisement -

Must Read 9   Well Said 7   News 5  
View Ratings | Rate It

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon


Go To Commenting

The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too